Valacyclovir Monotherapy in Pain Management of Acute Periapical Abscesses After Emergency Chamber Opening
Valacyclovir Monotherapy in Pain Management of Acute Apical Abscesses After Performing Emergency Chamber Opening; A Randomized Clinical Trial
Dow University of Health Sciences
82 participants
Mar 27, 2024
INTERVENTIONAL
Conditions
Summary
This study is aimed to evaluate the efficacy of valacyclovir in reducing postoperative pain following emergency chamber opening for acute apical abscess . There will be 82 participants, (41 in each group) Group A will receive Valacyclovir Group B will receive standard treatment i.e. Naproxen Sodium. Pain level will be assessed by using Numeric rating scale for 6 days
Eligibility
Inclusion Criteria4
- Patient Age ≥18 years old
- Healthy patient American Society of Anesthesiologists (ASA) class l and ll.
- Patients having clinical evidence of pulp necrosis and acute apical abscess with radiographic signs of periapical disease.
- to 3 as Mild pain. 4 to 6 as moderate pain. 7 to 10 as severe pain.
Exclusion Criteria5
- Patient currently on antibiotics or antivirals
- Smokers
- Unusual tooth anatomy or inaccurate diagnosis
- Pregnant or nursing mothers
- Patients allergic to valacyclovir
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Valtrex 2g immediate dose followed by 500mg 2 times daily for 3 days along with the analgesic (SOS, if needed) for 6 days
550mg (as needed, SOS) for 6 days
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06344195